47.61
+0.01(+0.02%)
Currency In USD
Address
27 West 24th Street
New York City, NY 10010
United States of America
Phone
646-481-9832
Sector
Healthcare
Industry
Biotechnology
Employees
74
First IPO Date
May 07, 2021
| Name | Title | Pay | Year Born |
| Dr. Sandeep C. Kulkarni M.D. | Co-Founder, Chief Executive Officer & Director | 848,250 | 1982 |
| Dr. Kevin B. Johnson M.B.A., Ph.D. | Chief Regulatory Officer | 555,835 | 1965 |
| Mr. Ryan Robinson CPA | Chief Financial Officer & Treasurer | 575,855 | 1989 |
| Mr. W. Bradford Middlekauff J.D. | Chief Business Officer, General Counsel & Corporate Secretary | 582,250 | 1962 |
| Dr. Susan Dana Jones Ph.D. | Chief Technology Officer | 0 | 1961 |
| Mr. Gerhard Hagn Pharm.D. | Senior Vice President and Head of Commercial & Business Development | 0 | N/A |
| Dr. Kristine Erickson O.D., Ph.D. | Vice President & TA Head of Ophthalmology, Medical Research | 0 | N/A |
| Ms. Dora Rau | Senior Vice President & Head of Quality | 0 | N/A |
| Ms. Kimberly Piorkowski | Vice President of People, Culture & Compliance | 0 | N/A |
| Dr. Emil M. deGoma M.D. | Senior Vice President of Medical Research | 0 | N/A |
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.